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Background: This study tested if second trimester amniotic fluid cytokine levels, Ureaplasma sp. colonisation and
sexual activity predict preterm birth and explain the differential preterm birth rates in Chinese compared to
Australian women.
Methods: Amniotic fluid was collected by amniocentesis (Chinese 480, Australian 492). Cytokines were measured
by multiplex assay and Ureaplasma sp. DNA was detected by PCR analysis. Lifestyle factors, including history of
smoking and sexual activity during pregnancy, were obtained through completion of questionnaires upon
recruitment to the study.
Results: Inflammatory cytokine concentrations were poorly predictive of preterm birth. Ureaplasma sp. was
detected in two of the Chinese pregnancies and none from Australia. Sexual activity was less frequent in Chinese,
and was not associated with preterm birth or amniotic fluid findings in either population.
Discussion: Second trimester amniocentesis for measurement of inflammatory markers and Ureaplasma sp. DNA
was not indicative of risk of preterm birth, at least in these populations. The lower rate of preterm birth in China
was not explained by differences in amniotic fluid inflammatory markers, Ureaplasma sp. colonisation, or sexual
activity.
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Preterm birth (PTB) is the leading cause of death and
disability in young children in the developed world [1,2].
In Australia, the rate of PTB is similar to the majority of
developed countries at 7-9% and has been increasing
over recent decades [3]. In contrast, the rate of PTB in
China is believed to be less than 4%. Previously, we have
reported that the PTB rate in Jiangsu Province, of which
Nanjing is the capital, is 2.6-2.9% [4]. Further, we ob-
served that migration of Chinese women from mainland* Correspondence: john.newnham@uwa.edu.au
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unless otherwise stated.China to westernised populations was associated with a
subsequent increase in risk of PTB. Chinese women in
Hong Kong without residency status had rates of 5-6%,
increasing to 7.6% for those with residency status, while
Chinese women in Western Australia had rates of 4.4%
compared to 7-8% in Australian Caucasians [4].
The reasons underpinning the different rates of PTB in
China and Australia are not understood. We previously
speculated that lifestyle differences, particularly attitudes
towards smoking and sexual activity during pregnancy,
may be involved. A subsequent study by Zhang et al. [5]
reported a significant association between sexual activity
and PTB in Chinese women. However, evidence to sup-
port a similar association in western populations is con-
flicting [6]. Due to the multifactorial nature of PTB, theretd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ticular the effects of infection and inflammation.
There is strong evidence that infection and inflamma-
tion are the leading causes of very early PTB and are
also involved to a lesser extent in later PTB [7]. In terms
of infection, numerous organisms have been associated
with PTB. These range from common sexually transmit-
ted disease-associated organisms such as Chlamydia tra-
chomatis [8] to the large number of anaerobic genera
associated with bacterial vaginosis [9]. However, intrauter-
ine tissues from preterm pregnancies are most frequently
colonised with Ureaplasma sp. and there is strong evi-
dence from both animal models [10,11] and human preg-
nancies [12,13] for a causal relationship between this
organism and PTB. In particular, several previous studies
have suggested significant associations between the pre-
sence of Ureaplasma sp. in amniotic fluid and sub-
sequent PTB [14-16]. For example, Yoon et al. [15]
isolated Ureaplasma sp. from the amniotic fluid of 11/181
(6.1%) women in preterm labor and reported significantly
higher rates of PTB within 48 h, 72 h and 7 days of amnio-
centesis for these women. Ureaplasma sp. colonisation of
the vagina, the likely source of amniotic fluid infection,
has also been widely examined for potential association
with PTB; however, evidence for such an association has
been inconsistent [17].
Measurements of second trimester amniotic fluid cyto-
kine and chemokine levels have previously been explored
to identify women at an elevated risk of PTB [18-20] and
diagnose intrauterine infection [21,22]. In particular, el-
evated levels of amniotic fluid interleukin-6 (IL-6) have
been reported as predictive of intrauterine infection
[21-24], as well as predictive of PTB in the absence
of symptomatic clinical infection [18,24]. In addition
to IL-6, associations between infection/inflammation/
PTB and a wide range of other amniotic fluid cytokines
and chemokines have been described. Examples include
interleukin-8 (IL-8) [20-22,24], interleukin-1β (IL-1β)
[21,23], interleukin-10 (IL-10) [20,21], monocyte chemotac-
tic protein-1 (MCP-1) [25-27], matrix-metalloproteinase-8
(MMP-8) [18] and tumour necrosis factor-alpha (TNF-α)
[21,23].
It has been suggested that because intra-amniotic in-
flammation is heterogeneous, not all cases of elevated
cytokine/chemokine levels can be predictive of adverse
pregnancy outcome [19]. Further, racial factors may be
involved. Peltier et al. [21] described differing pro and
anti-inflammatory properties of amniotic fluid between
European-Americans and African-Americans, as well as
differing responses depending on the particular agonist
involved. These authors suggested that assessment of bio-
markers for prediction of pregnancy outcome may need to
be customised according to race, in addition to the agonist
responsible for causing the inflammation.To our knowledge, there are no published reports de-
scribing the prevalence of intraamniotic Ureaplasma sp.
colonisation in Chinese women, or comparing amniotic
fluid cytokine/chemokine levels between Chinese and
Western populations. We hypothesised that lower rates
of Ureaplasma sp. colonisation of amniotic fluid, dif-
ferences in the intraamniotic inflammatory response to
such colonisation, and related lifestyle factors, may ex-
plain the apparent differences in preterm birth rates be-
tween the two populations.
The aims of this study were, therefore, to describe the
levels of inflammatory cytokines IL-1β, IL-6, IL-10, TNF-α
and the chemokine MCP-1 and colonisation rates of
Ureaplasma parvum and Ureaplasma urealyticum in
2nd trimester amniotic fluid samples from Chinese and
Australian women; and to evaluate the association be-
tween these variables, lifestyle factors including smoking
and sexual activity during pregnancy, and PTB. If individ-
ual, or a combination, of inflammatory and infectious
markers were to be strong predictors of early PTB, amnio-
centesis early in the 2nd trimester in cases suspected to be
at high risk could become a useful clinical tool.
Methods
Subjects
The study consisted of two cohorts of women from whom
amniotic fluid samples and clinical outcome data were
available: 512 from Drum Tower Hospital, Nanjing, China
and 564 from King Edward Memorial Hospital (KEMH),
Perth, Western Australia.
Women with a singleton pregnancy were eligible for
inclusion if they had been referred for genetic amnio-
centesis. In the Australian cohort, indications to conduct
this procedure were primarily to exclude aneuploidy based
on high risk findings at either first trimester screening
(ultrasound measurement of fetal nuchal translucency and
maternal biochemistry) or second trimester maternal
serum screening (maternal biochemistry) with no appar-
ent fetal structural anomalies. In the Chinese cohort, the
indications for amniocentesis included advanced maternal
age, nuchal translucency screening and maternal request.
In all pregnancies, gestational age was determined by ul-
trasound imaging and biometry in the first or early second
trimester. Participants were required to possess language
fluency sufficient to understand the implications of par-
ticipation. Cases subsequently shown to be complicated
by aneuploidy were withdrawn and the amniotic fluid not
analysed further.
All amniocenteses were performed between 15 and
20 weeks gestation. Written informed consent was ob-
tained by the attending medical practitioner or midwife.
Approval for the study was obtained from the ethics
committees of Drum Tower Hospital, Nanjing, China
(2011037), the Women and Newborn Health Service,
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Western Australia (RA/4/1/4784).
The preterm birth rate in the entire Chinese sample of
1865 pregnancies was 3.4%, consistent with previous ob-
servations in this population [4]. In view of the cost of
analyses, the Chinese group was enriched with cases of
preterm birth; the final sample included all cases of pre-
term birth (63 cases) and a random selection of term
births producing a sample of 512 cases. Of these, 32
cases were excluded due to inadequate follow-up data,
leaving 480 for analysis.
564 consecutive cases in the Australian group were in-
cluded in the study, of which 72 were lost to follow-up
leaving 492 for analysis.
Questionnaire
Prior to amniocentesis, women were invited to complete
a de-identified lifestyle questionnaire in a private setting.
The questionnaire inquired about smoking practices as
yes or no, and then sought to quantify the number of
cigarettes smoked each day in those who declared them-
selves to be smokers. Sexual activity during pregnancy
was assessed by inquiring about the number of episodes
of sexual intercourse during the pregnancy. Responses
to this question were categorised as: 1) On most days/
daily; 2) 2–3 times each week; 3) About once each week;
4) Less than once each week; and 5) Not at all. Informa-
tion regarding any vaginal bleeding in the two weeks
preceding amniocentesis was also recorded.
Pregnancy outcome data
Pregnancy outcome data were accessed by review of the
medical records after completion of the pregnancy.
Sample collection
Amniocenteses were conducted by medical specialists
under ultrasound guidance at 15–20 weeks gestational
age (GA). Three millilitres of amniotic fluid were aspi-
rated in addition to the 10–15 mL collected for clinical
measurement and subsequently dispensed into 1 mL ali-
quots in sterile cryovials prior to storage at −80°C.
Sample preparation and processing - Chinese
pregnancies
From each participant, 1.5 mL of amniotic fluid was
centrifuged at 15,000 × g for 10 min. Supernatant was
removed and frozen at −20°C or −80°C for cytokine ana-
lyses. The pellet and approximately 100 μL of residual
supernatant was subsequently frozen at −20°C for later
DNA extraction.
DNA extraction
Pelleted amniotic fluid samples were thawed and trea-
ted with proteinase K (0.2 mg/mL) (Sigma, Saint Louis,USA) at 50°C for 3 h. DNA was subsequently extracted
using two phenol-chloroform separations and rinsed once
with 70% ethanol following centrifugation at 10,000 × g.
DNA was eluted in 25 μL Tris-EDTA buffer and frozen
at −20°C prior to PCR analysis.
PCR analysis
For detection of Ureaplasma sp. DNA, amniotic fluid
DNA was screened using PCR analysis. Analysis was
performed using two end-point PCR assays targeting the
multiple-banded antigen and urease genes of U. parvum
and U. urealyticum as described by Stellrecht et al. [28].
For each assay, reaction mixtures consisted of: 1.25 units
of Taq DNA polymerase (Takara, Dalian, China), 12.5 μL
template DNA, 2 mM MgCl2, 0.2 mM dNTPs and 0.3 μM
primers; water was added to a final volume of 50 μL. PCR
cycling conditions consisted of an initial denaturation at
94°C for 3 min followed by 35 cycles of 94°C for 30 s,
55°C for 30 s and 72°C for 40 s. A final extension step
was performed at 72°C for 5 min. PCR products were
visualised by electrophoresis on a 1.5% agarose gel stained
with ethidium bromide, and were photographed using an
ultra-violet image analysis system (UVP, Upland, CA).
Sequencing of MBA amplicons
For positive samples, to confirm species identity, MBA
amplicons were purified using TIANquick Midi Purifica-
tion kits (Tiangen Biotech, Beijing, China) and directly
sequenced on an ABI Prism 3130 sequencer (Applied
Biosystems, Hitachi, Tokyo, Japan) using BigDye Termin-
ator v3.1 chemistry (Applied Biosystems, Foster, CA) as
per manufacturer’s instructions. Sequences were analysed
using the Basic Local Alignment Search Tool (BLAST)
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) for comparison
against already established Ureaplasma sp. MBA gene
sequences.
Sample preparation and processing - Australian
pregnancies
For each participant, 1 mL of amniotic fluid was thawed,
centrifuged at 16,100 × g, 4°C for 30 min and the super-
natant transferred to a 1.5 mL microfuge tube, placed on
ice and assayed immediately for cytokine analyses. The
pellet and approximately 100 μL of residual supernatant
were then frozen at −80°C until DNA extraction.
DNA extraction
Amniotic fluid pellets were thawed and the total volume
adjusted to approximately 250 μL with PBS (Sigma
Aldrich, St Louis MO). DNA was extracted using the Ver-
sant Sample Preparation Kit 1.0 (Siemens AG, Erlangen,
Germany) on the Kingfisher Duo automated extraction
platform (Thermo Fisher Scientific, Vic, Australia) as per
manufacturer’s recommendations, and frozen at −20°C
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control consisting of approximately 250 colour changing
units (CCU) each of U. parvum and U. urealyticum was
included in all runs.
Real-time PCR analysis
For detection of Ureaplasma sp. DNA, amniotic fluid
DNA was analysed using a real-time PCR assay targeting
the urease gene of U. parvum and U. urealyticum as
described by Yi et al. [29], adapted for use on a ViiA7
real-time PCR thermocycler (Life Technologies, Carlsbad,
California, USA). Reaction mixtures (final volume or
concentration) consisted of: 1X Taqman FAST Advanced
Master Mix (Life Technologies), 0.9 μM primers UU1613F
and UU1524R (Life Technologies), 0.25 μM probes
UU-parvo (FAM) and UU-T960 (VIC) (Life Technologies),
5 μL of template DNA and nuclease-free water (Ambion)
to a final volume of 20 μL. PCR cycling conditions con-
sisted of an initial denaturation/Taq activation at 95°C for
20 s, followed by 40 quantification cycles of 95°C for 1 s
and 60°C for 20 s (data acquiring).
Cytokine/chemokine analysis – Chinese and Australian
pregnancies
Concentrations of IL-1β, IL-6, IL-10, TNF-α and MCP-1
were determined by multiplex assay using the Milli-
plex MAGPIX system (EMD-Millipore/Merck KGaA,
Darmstadt, Germany) as per manufacturer’s instructions.
Briefly, individual wells of 96-well plates were loaded in
duplicate with either: 25 μL of prepared standard solution,
25 μL of amniotic fluid supernatant or 25 μL of quality
control. 25 μL premixed antibody-coated beads were then
added to all wells. Plates were incubated at 500 RPM, 4°C,
overnight in the dark and then washed twice with 200 μL
wash buffer followed by magnetic precipitation prior to
the addition of 25 μL of detection antibody. Plates were
then incubated at room temperature for one hour, 300
RPM in the dark. 25 μL of streptavidin-phycoerythrin con-
jugate was subsequently added to each well and the plate
again incubated at room temperature for 30 min, 300
RPM in the dark. Plates were washed twice more with
wash buffer and following magnetic precipitation the la-
belled beads were resuspended in 150 μL of drive fluid for
measurement in the MAGPIX instrument.
The calibration curve range for all cytokines/chemo-
kines was initially 3.2 – 10,000 pg/mL according to the
manufacturer’s instructions. Samples which were below
this limit were subsequently re-assayed with an extended
standard curve range that provided a minimum level of
detection of 0.64 pg/mL. To assess comparability between
assays performed in China and Australia, two sets of com-
mercial QCs (Randox Life Sciences, County Antrim,
Northern Ireland) representing low and high values, re-
spectively, were measured with each run. The same lotnumbers of QCs and Milliplex MAGPIX assays were
employed by both laboratories to minimise variability.
In order to ensure comparability of the cytokine values
between the Chinese and Australian groups, the values
were adjusted to normalise the quality control values
(Additional file 1: Table S1) across both groups.
Statistical analyses
Adjustment factors were required in this study to account
for the fact that all laboratory measurements had be done
in the country of origin of the sample as it is illegal to im-
port or remove human samples to or from China.
Continuous data were summarised using means and
standard deviations or medians, interquartile ranges (IQR)
and ranges (R), as appropriate for data normality. Categor-
ical outcomes were summarised using frequency distribu-
tions. Univariable comparisons of cytokines/chemokines
and lifestyle and pregnancy features/outcomes were
based on Mann–Whitney or Kruskal-Wallis tests and
Chi-square or Fisher exact tests for continuous and ca-
tegorical data as required. Apart from the compari-
sons of cytokine/chemokine levels between Chinese and
Australian pregnancies, all analyses were performed using
Chinese pregnancy data or Australian pregnancy data
alone. The effects of cytokine/chemokine levels at amnio-
centesis on gestational age at delivery and PTB were in-
vestigated using Cox proportional hazards regression with
hazard ratios (HR) and logistic regression analysis with
odds ratios (OR) and their 95% confidence intervals (CI)
used as summaries. Multivariable effects of cytokines/che-
mokines were examined while considering adjustments
for other relevant risk factors without model overfitting.
SPSS version 20 (SPSS IBM, New York, USA) statistical




Data from the 480 Chinese and 492 Australian women
and their pregnancies are shown in Table 1. The preterm
birth rate in the Chinese group, after enrichment, was
13.1% (increased from an initial rate of 3.4%) and in the
Australian group was 10.6%.
Detection/quantitation of cytokines
Minimum, median (IQR) and maximum cytokine values
detected in amniotic fluid from the Chinese and Australian
pregnancies are presented in Table 2. Levels of IL-10
(median 7.3 vs. 6.3 pg/mL), MCP-1 (median 1145 vs.
811.1 pg/mL) and TNF-α (median 6.5 vs. 5.6 pg/mL) were
significantly lower in Australian pregnancies (P < 0.001
for each variable). There were no significant differences
in IL-1β and IL-6 between Chinese and Australian
pregnancies.
Table 1 Maternal characteristics of the Chinese and
Australian pregnancies
China (n = 480) Australia (n = 492)
Nulliparity 308 (64.2%) 170 (34.6%)
Maternal age; median
(interquartile range; range)






Did not answer N/A 116
Smoking in pregnancy 3 (1%) 66 (13.4%)
Preterm birth 63 (13.1%)1 52 (10.6%)
Threatened abortion 1 (0.2%) 15 (3.0%)
Gestational age (GA),
preterm (min – max)
28-36 21-36
<28 weeks - 6 (1.2%)
28-32 weeks 5 (1.0%) 3 (0.6%)
33-36 weeks 58 (12.1%) 43 (8.7%)




77 (16.0%) 68 (13.8%)
Preterm PROM 27 (5.6%) 19 (3.9%)
1The preterm birth rate in the Chinese sample was enriched from an initial
rate of 3.4%.
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kine levels and either maternal age or fetal sex within
pregnancies from either country, although within the
Chinese pregnancies median IL-10 values tended to be
higher in males (9.1 vs. 7.9 pg/mL).
Gestational age at delivery/preterm birth
Within Chinese pregnancies, elevated IL-10 levels (defined




China 0.8 (0.6 - 1.4) 74.4 (46.8 - 154.1) 7
[range: 0.6 - 6.6] [range: 9.5 - 1675] [r
N = 479 N = 480 N
Australia 0.9 (0.6 - 1.4) 91.0 (39.7 - 206) 6
[range: 0.6 - 6.5] [range: 32 - 6402] [r
N = 436 N = 421 Nearlier gestational age at delivery (P = 0.012; HR = 1.27;
95% CI: 1.05-1.53). The median levels of IL-10 were also
significantly higher in Chinese but not Australian preg-
nancies for PTB defined as birth before 37 completed
weeks (P = 0.009; OR = 2.25; 95% CI: 1.23-4.13) (Figure 1).
In amniotic fluid from either country, there was no associ-
ation between levels of any other cytokine and either de-
livery at an early gestational age or PTB.
There was a significant association between elevated
IL-10 levels (i.e. >10.1 pg/mL) in Chinese pregnancies
and pre-labour rupture of membranes (PROM) (P =
0.008; HR = 1.84; 95% CI: 1.17-2.88). High levels of IL-10
within Australian pregnancies were not associated with
PROM (P = 0.578), while elevated TNF-α levels were pa-
radoxically associated with decreased likelihood of PROM
(P = 0.031; HR = 0.46; 95% CI: 0.22-0.93). No other cyto-
kines were associated with PROM in pregnancies from
either country.
Smoking during pregnancy
Smoking during pregnancy was rare amongst Chinese
pregnancies (1%) with only three women reported to be
smokers. Amongst Australian pregnancies 13.4% of wo-
men smoked. The rate of PTB in Australian smokers
was 16.7% compared with 9.3% in non-smokers. In the
Australian pregnancies, smoking was significantly associ-
ated with increased amniotic fluid IL-6 levels (median
171.5 vs. 89.0 pg/mL)(P = 0.001).
Sexual intercourse during pregnancy
Rates of sexual intercourse reported by Chinese women
were less frequent than rates reported by Australian
women (Figure 2) (P <0.001). There was no significant
association between rates of sexual intercourse and
PTB in either Chinese or Australian women (P = 0.329
and P = 0.407 respectively) (Figure 3). Further, after
combining the data from both groups, there remained
no statistical association between frequency of sexual
intercourse and PTB. There was also no significant
association between frequency of sexual intercoursenterquartile range [range]) in Chinese and Australian
-10 MCP-1 TNF-α
.3 (4.9 - 11) 1145 (889 - 1462) 6.5 (5.2 - 7.9)
ange: 2.9 - 417] [range: 312 - 7635] [range: 2.4 - 81.0]
= 480 N = 480 N = 480
.3 (3.5 - 9.0) 811 (559 - 1114) 5.6 (3.6 - 7.4)
ange: 3.2 - 93.1] [range: 3.0 - 9300] [range: 3.2 - 19.1]
= 449 N = 438 N = 451
Figure 1 Box and whisker plots illustrating the associations between amniotic fluid IL-10 levels and PTB in Chinese and Australian
pregnancies. PTB was significantly associated with increased amniotic fluid IL-10 levels in Chinese but not Australian pregnancies (P = 0.009).
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pregnancies from either country (all P >0.05) (Figure 4).
Data were not available from 203 Chinese women of
whom 195 were administered the questionnaire and
eight chose not to respond. Eight Australian women
also declined to answer this question.Threatened abortion
Threatened abortion in the two weeks before the amnio-
centesis was reported in only one case of the Chinese
pregnancies. Within the 15 Australian pregnancies com-
plicated by recent threatened abortion, there was a sig-
nificant association with elevated levels of IL-6 (median
285.7 vs. 88.6 pg/mL; P = 0.024) and IL-10 (median
11.6 vs. 6.1 pg/mL; P = 0.001). Levels of IL-1β wereFigure 2 Reported frequency of sexual intercourse during pregnancy
women was significantly less than in Australian women (P < 0.001).also increased in these cases (median 1.1 vs. 0.9 pg/mL;
P = 0.05).
Detection of Ureaplasma sp. DNA and preterm birth/
cytokine association
Two amniotic fluid samples were positive for U. parvum
DNA from Chinese pregnancies. Both women from whom
these samples were obtained delivered preterm, one at
29 weeks and the other at 34 weeks gestation. Both these
women had significantly elevated cytokine levels for
every cytokine measured relative to mean levels (Table 3).
U. urealyticum DNA was not detected in any of the
Chinese samples. In the amniotic fluid samples from
Australian women, there were no cases in which U.
parvum or U. urealyticum was detected. Extraction
controls were positive in all assays.in Chinese and Australian women. The rate reported by Chinese
Figure 3 Reported frequency of sexual intercourse during pregnancy and rates of PTB in Chinese and Australian women. There was no
significant association between these rates and PTB in either group.
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In this study, we have explored the hypothesis that am-
niotic fluid cytokines/chemokines and Ureaplasma sp.
colonisation sampled by amniocentesis early in the se-
cond trimester may be useful to predict PTB, thus en-
abling therapeutic interventions aimed at prevention. In
addition, we have compared amniotic fluid from popu-
lations of pregnant women in China and Australia to
investigate whether either of these factors can help to
explain the major differences seen in rates of PTB inFigure 4 Reported frequency of sexual intercourse during pregnancy
pregnancies. There were no associations between sexual activity and cytothese countries, in particular why westernisation appears
to be associated with an increased rate of PTB in Chinese
women. Amniotic fluid inflammatory cytokines/chemo-
kines were in general not predictive of PTB, although ele-
vated IL-10 levels were associated with PTB and PROM
in Chinese pregnancies. In Australian pregnancies, low
levels of TNF-α were unexpectedly associated with subse-
quent PROM. The differential responses between these
two populations most likely represent a combination
of racially-specific factors and response to intrauterineand amniotic fluid cytokine levels in Chinese and Australian
kine levels in either group.
Table 3 Comparison of median cytokine levels in
amniotic fluid from two Ureaplasma sp. DNA positive
Chinese women who delivered preterm
Cytokine (pg/mL)
IL-1β IL-6 IL-10 MCP-1 TNF-α
Participant 1 2.59 1675.5 417.1 5161 81.0
Participant 2 1.89 435.9 238.1 7635 61.1
All group median 0.8 74.4 7.3 1145 6.5
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profiles have been described previously by Velez et al.
[30] who reported that within European-American and
African-American women there appears to be differen-
tial genetic control of amniotic fluid levels of IL-6. Subse-
quently, Menon et al. [31] showed a significant association
between IL-6 levels and PTB in Caucasians, but not in
African-Americans. In addition, these authors found no
association between amniotic fluid IL-10 levels and PTB,
whereas in the present study we observed a small but sig-
nificant association between amniotic fluid IL-10 levels
and PTB in Chinese pregnancies. This observation sug-
gests that within Chinese women, inflammation-driven
PTB is likely triggered through production of different
pro- and anti-inflammatory cytokines. Such a possibil-
ity has been suggested by data from another study by
Menon et al. [32] with respect to African-Americans and
Caucasian-Americans. These authors reported higher am-
niotic fluid levels of IL-1β and IL-8 in both groups, but
elevated IL-1β levels were only associated with PTB in
African-Americans. Most recently, these authors [33] ex-
amined the association between single nucleotide poly-
morphisms in cytokine and cytokine-related genes with
amniotic fluid levels of IL-1β, IL-8 and IL-10 from
term and preterm births amongst African-Americans
and Caucasian-Americans. It was concluded that genetic
regulation of cytokine levels during pregnancy was likely
related to ethnicity and, in particular, that amniotic
fluid cytokine levels were linked to interactions between
PTB and genotype in African-Americans, but less in
Caucasian-Americans. An examination of the nucleo-
tide composition of cytokine-related genes during preg-
nancy within Chinese and Australian women would be
of interest to potentially explain the difference in levels
observed in the present study.
In addition to the direct impact of racially-specific ge-
netic factors on cytokine regulation within the amniotic
fluid, recent research has also reported racially-specific
amniotic fluid cytokine responses to different intrau-
terine agonists. Using cultured fetal membranes from
European-American and African-American women ex-
posed to a range of bacteria, Peltier et al. [21] demonstra-
ted organism-specific cytokine responses that differed
between the two cohorts. For example, IL-1β and TNF-αproduction was up-regulated in the presence of lipo-
polysaccharide (LPS), Escherichia coli and Gardnerella
vaginalis relative to control. In addition, within their stu-
dy, African-Americans showed double the IL-1β response
to E. coli compared with European–Americans. In con-
trast, IL-8 production in response to LPS was significantly
up-regulated in European-Americans compared to African-
Americans. The results of the present study support the
view that race should be considered when interpreting
cytokine responses in PTB prediction.
In the present study, we detected Ureaplasma sp. DNA
in only two of the 480 amniotic fluid samples from
Chinese women and did not detect any in the 492 am-
niotic fluid samples from Australian women. The two
Chinese cases where Ureaplasma sp. DNA was detected
were associated with significantly elevated levels of all
cytokines measured. A similar result was reported by
Jacobssen et al. [34], who described an association be-
tween TNF-α levels and presence of Ureaplasma sp.
DNA in amniotic fluid from women with PTL and
PPROM. However, in contrast, this study found no
association between levels of IL-1β, IL-6 and IL-10
and detection of Ureaplasma sp. DNA.
Differences in the rates of Ureaplasma sp. DNA detec-
tion in the current study are unlikely to have arisen from
the differences in the DNA extraction and PCR method-
ology utilised by the two collaborative laboratories. Due
to the lack of a cell wall, lysis of Ureaplasma sp. cells is
readily achieved and both PCR assays were validated for
Ureaplasma sp. detection. It is possible that due to the
use of end-point PCR for screening of Chinese amniotic
fluid samples, trace levels of Ureaplasma sp. DNA may
not have been detected; such amounts, however, are un-
likely to be clinically relevant. The very low detection rate
of Ureaplasma sp. DNA in both sets of mid-trimester
amniotic fluid samples is in stark contrast to previously
reported observations in other populations. For example,
several previous studies have reported Ureaplasma sp.
within the amniotic fluid of women with preterm labour
(PTL) and/or preterm premature rupture of membranes
(PPROM), with detection rates ranging from 3.3% [35] to
63% [36]. Of particular significance is the case–con-
trol study by Gerber et al. [36], who described a significant
association between presence of Ureaplasma sp. DNA in
second trimester amniotic fluid and subsequent PTL.
Similar associations have been described by Yoon et al.
[14,15] and Oh et al. [16] in case-specific studies. How-
ever, in contrast, within amniotic fluid from women who
delivered at term, detection rates for Ureaplasma sp. ran-
ging from 0% [37] to 5.3% [36] have been described.
As the current study is the first of its kind to examine
amniotic fluid from both Chinese and Australian po-
pulations, there are no geographically comparable data
against which our data can be compared. However, a
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women described the prevalence rate of Ureaplasma
sp. within vaginal and endocervical samples as 57% and
17% respectively [34]. This is comparable to that re-
ported in a range of vaginal prevalence studies conduc-
ted on different geographical cohorts of pregnant women
[17]. The rate of colonisation in cervical swabs, however,
is somewhat lower than that reported previously in a
Chinese population. Kong et al. [38] collected 400 cer-
vical swabs from sex workers (200), women attending a
sexually-transmitted infection (STI) clinic (100) and preg-
nant women (100), and detected Ureaplasma sp. in 185/
400 (46.3%) swabs. Interestingly, Ureaplasma sp. was de-
tected significantly more frequently in swabs from preg-
nant women (58%) compared to sex workers or women
attending the STI clinic (42.3%). These studies at the very
least provide evidence that Ureaplasma sp. have the po-
tential to invade the amniotic cavity in both Australian
and Chinese women, based upon the theory of vaginal
ascension [7]. Our results instead suggest that if Urea-
plasma sp. do ascend into the amniotic cavity during
pregnancy in these women, then they do so primarily
at a time point after 20 weeks’ gestation. Taking this
into account, particularly within the Australian setting,
amniocentesis prior to 20 weeks gestation for detec-
tion of Ureaplasma sp. as an early predictive marker
of PTB is unlikely to be a useful investigational tool.
Unfortunately, it is rarely clinically possible to obtain
amniotic fluid samples opportunistically after 20 weeks
gestation as is the case with genetic amniocentesis in
the early second trimester [39].
Our study observed significantly increased levels of
amniotic fluid IL-6 in Australia women who smoked
during pregnancy. Although it is well established that
smoking during pregnancy is associated with PTB [40,41],
the effect of smoking on inflammatory responses within
the amniotic cavity has been relatively unexplored. Pre-
vious studies have shown that smoking does influence
cytokine levels in other bodily fluids. For example, Sazak
et al. [42] demonstrated increased levels of erythropoi-
etin within the umbilical cord blood of infants born to
smokers and suggested that this finding may indicate a
risk of fetal hypoxia and growth restriction. In contrast,
Etem Piskin et al. [43] reported that levels of some cyto-
kines in colostrum and breast milk were significantly
lower in smokers.
Within Australian pregnancies we observed a signi-
ficant association between elevated levels of IL-6 and
IL-10 and vaginal bleeding within the previous two weeks.
A recent study by Bamberg et al. [44] found that ele-
vated amniotic fluid levels at 15–20 weeks gestation
of IL-6, IL-8 and TNF-α were not predictive of spon-
taneous abortion in a study of 298 women with un-
complicated singleton pregnancies. To the best of ourknowledge, our observation of elevated IL-10 levels
following threatened abortion has not been described
previously.
We previously suggested that differences in frequency
of sexual intercourse between Chinese and Caucasian
women in pregnancy may help to explain some of the
disparity in PTB rates between the two groups [4]. While
the current study demonstrated a significantly higher rate
of sexual activity during pregnancy amongst Australian
women, there was no evidence to suggest any association
between frequency of sexual intercourse during pregnancy
and either PTB or any individual amniotic fluid cytokine
level. This result is similar to previous studies which either
found no association between sexual activity during preg-
nancy and recurrent PTB [45] or actually described a
reduced risk of PTB following intercourse during late
pregnancy [6]. These data are all in contrast to the data
presented by Zhang et al. [5] however, which suggested an
almost two-fold increased risk of PTB in Chinese women
who had sexual intercourse during pregnancy. It is im-
portant to note, however, that this study did not document
the frequency of intercourse; it instead documented
whether intercourse occurred at all during pregnancy. It
also attempted to ascertain during what trimesters this oc-
curred but did not receive a high compliance rate with this
question (32.1% of subjects). To our knowledge, our study
is the first of its kind to document sexual activity during
pregnancy alongside levels of amniotic fluid inflammatory
cytokines as potential indicators for risk of inflammation-
driven PTB.
The present study is the first of which we are aware to
compare data from Chinese and Western pregnancies.
We have attempted to standardise all measurements to
provide consistency between the two groups. Analyses,
however, were complicated by two issues. First, it is il-
legal to remove or import any human samples from or
into China, precluding the opportunity to conduct the
measurements in one of the collaborating laboratories.
Hence, we used identical measurement systems for am-
niotic fluid cytokines and comparable PCR methods for
detection of Ureaplasma sp. DNA. Second, the low rate
of PTB in the Chinese population required us to retro-
spectively enrich the sample to increase the rate of PTB.
Conclusions
In conclusion, this study has shown that measurement
of amniotic fluid inflammatory markers and detection
of Ureaplasma sp. DNA in samples obtained early in
the second trimester are not clinically useful as predic-
tors of risk of preterm birth. The rarity of Ureaplasma
sp. DNA in these two populations of pregnant women
is in marked contrast to findings from other popula-
tions, highlighting the importance of conducting re-
search in different countries and population groups.
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amongst Chinese women and was not correlated with
amniotic fluid inflammatory markers, presence of Urea-
plasma sp. DNA or risk of PTB. These findings do not
support the hypothesis that sexual activity in pregnancy is
a cause of preterm birth.
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